- Report
- April 2023
- 112 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- October 2022
- 110 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- August 2022
- 105 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- August 2022
- 115 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- January 2022
- 115 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- January 2022
- 105 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- July 2021
- 120 Pages
Global
From €4230EUR$4,750USD£3,692GBP
- Report
- June 2024
- 68 Pages
Europe
From €2627EUR$2,950USD£2,293GBP
- Report
- February 2024
- 71 Pages
Asia Pacific
From €2627EUR$2,950USD£2,293GBP
- Report
- January 2024
- 62 Pages
Europe
From €2627EUR$2,950USD£2,293GBP
- Report
- December 2023
- 137 Pages
Global
From €2204EUR$2,475USD£1,924GBP
€4408EUR$4,950USD£3,847GBP
- Report
- December 2023
- 153 Pages
Global
From €2204EUR$2,475USD£1,924GBP
€4408EUR$4,950USD£3,847GBP
- Report
- December 2023
- 155 Pages
Global
From €2204EUR$2,475USD£1,924GBP
€4408EUR$4,950USD£3,847GBP
- Report
- July 2022
- 195 Pages
Global
From €2338EUR$2,625USD£2,040GBP
€4675EUR$5,250USD£4,080GBP
- Report
- June 2022
- 207 Pages
Global
From €2338EUR$2,625USD£2,040GBP
€4675EUR$5,250USD£4,080GBP
- Report
- February 2022
- 199 Pages
Global
From €2338EUR$2,625USD£2,040GBP
€4675EUR$5,250USD£4,080GBP
- Report
- March 2024
- 147 Pages
Global
From €2270EUR$2,549USD£1,981GBP
€2671EUR$2,999USD£2,331GBP
- Report
- March 2023
- 350 Pages
Europe
From €2270EUR$2,549USD£1,981GBP
€2671EUR$2,999USD£2,331GBP
- Report
- September 2025
- 70 Pages
India
From €3117EUR$3,500USD£2,720GBP
- Report
- August 2025
- 82 Pages
India
From €3117EUR$3,500USD£2,720GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more